Navigation Links
Raloxifene Cuts Risk of Certain Type of Breast Cancer
Date:6/11/2008

And the benefits weren't limited to high-risk women, study finds

WEDNESDAY, June 11 (HealthDay News) -- A drug already approved to reduce the risk of breast cancer in high-risk women also seems to cut the risk for other women.

A new analysis finds that those who took raloxifene (Evista) regularly over a number of years were less likely to develop invasive estrogen-receptor (ER) positive breast cancer, compared with women who did not take the drug.

Raloxifene did not, however, cut the risk for noninvasive breast cancer or invasive ER-negative cancers.

"This is a reaffirmation that the drug raloxifene is a very powerful SERM [selective estrogen receptor modulator] for reducing the risk of invasive breast cancer," said Dr. Jay Brooks, chief of hematology/oncology at Ochsner Health System in Baton Rouge, La.

The study, published in the June 10 online issue of the Journal of the National Cancer Institute, was funded by Eli Lilly and Co., which makes Evista.

SERMs block the female hormone estrogen by binding to estrogen receptors; estrogen helps fuel the growth of some breast cancers. Raloxifene and other hormonal therapies have an "estrogenic tickle" effect, explained V. Craig Jordan, author of an accompanying editorial in the journal and vice president and research director for medical science at Fox Chase Cancer Center in Philadelphia. Jordan did some of the early laboratory research on raloxifene.

Raloxifene was originally developed to prevent and treat osteoporosis, and only later was found to help reduce the risk of invasive breast cancer in high-risk women.

The new study expands on the original results of the RUTH (Raloxifene Use for the Heart) trial, originally designed to see if raloxifene, which has cholesterol-lowering properties, could reduce the risk of dying from coronary heart disease.

The trial involved more than 10,000 postmenopausal women with
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Raloxifene Safe for Women With Decreased Kidney Function
2. Consumers Urged to Avoid Certain Tomatoes Amid Salmonella Scare
3. Demonstrating the Value of Benchmarking in an Uncertain Economy
4. St. Jude finds young age may give survival advantage to children with certain brain tumors
5. Certain Tests in ERs Raise Cancer Risk for Some
6. Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer
7. Gypsum Wallboard from CertainTeeds Moundsville, W. Va., Plant and Roofing Shingles among Building Materials Donated to St. Jude Dream Home(R)
8. Regular prostate-specific antigen screening may be discontinued in certain elderly populations
9. Experimental drug shows promise in treating certain lymphomas
10. Study finds certain liver disease related to cardiovascular fitness
11. Womens Risk for a Certain Skin Cancer Varies by Geography
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... , ... September 03, 2015 , ... ... Scholarship applications are open for spring 2016. Scholarships are awarded two times each ... For The Warriors® is a national nonprofit dedicated to restoring a sense of ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... landscape by connecting accredited and institutional investors to real estate investment opportunities nationwide, ... to meet demand from both investors and sponsoring real estate companies. ...
(Date:9/3/2015)... ... September 03, 2015 , ... The Linda Hall Library 2015 ... a comet, the IceCube observatory at the South Pole, and the interior of life-extending ... Lecture Series for the world's foremost independently funded research library devoted to science, engineering, ...
(Date:9/3/2015)... , ... September 03, 2015 , ... Dr. Robert Winchell ... Trauma, Burns, Critical and Acute Care at NewYork-Presbyterian/Weill Cornell Medical Center, effective July 27. ... is a nationally renowned expert in care for the critically injured and the development, ...
(Date:9/3/2015)... ... 2015 , ... Atlantic Information Services, Inc. (AIS) is pleased ... for a Rapidly Changing Marketplace.” In this Sept. 16 program, pharmacy benefit experts ... plan sponsors are adopting bold, innovative strategies to control soaring specialty pharmacy and ...
Breaking Medicine News(10 mins):Health News:Hope For The Warriors Spouse/Caregiver Scholarships Now Open for Spring 2016 2Health News:RealtyShares Announces Mezzanine Financing Products 2Health News:RealtyShares Announces Mezzanine Financing Products 3Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 2Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 3Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 4Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 5Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 2Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 3Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 4Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 5Health News:Speakers for Upcoming AIS Virtual Conference on Pharmacy Benefit Strategies Include Executives from CVS Health, Express Scripts 2
... the Calcutta High Court claiming that the failure of West ... directives in keeping the metropolis clean had led to the ... has died and several others are suffering from dengue with ... ,The petitioner's lawyer Idris Ali claimed before a division ...
... Recent research by Canadian scientists has revealed that ... of autism//. ,McGill University Health Center scientists ... in 28,000 children and reported their findings in ... that autism rates were actually higher in children ...
... study has found that fifty percent of adults who ... during their childhood thereby linking childhood //obesity to the ... in adulthood. ,Metabolic syndrome is a cluster of ... pressure, low levels of HDL "good" cholesterol, high fasting ...
... women who are at risk for infertility and needing ... in vitro when immature follicles were removed from their ... at the Northwestern University have created a new technology ... normal follicular maturation in vitro and helped maintain a ...
... to a report by Dr. Jack Tu it was found ... factors, treatments//, and outcomes of heart disease for the more ... Canadian Cardiovascular Outcomes Research Team (CCORT) Atlas Editor and Senior ... there is an East to West gradient in terms of ...
... in the United States to begin studies about a vaccine ... smoking//. ,Nic vax, the name of the vaccine is ... on the shelves in 2 years time. ,The ... and impairs them. This results in obliterating the urge to ...
Cached Medicine News:Health News:A three-dimensional Culture System ensures Female Fertility 2Health News:Location Influences Mortality Rate of Cardiovascular Diseases 2
(Date:9/3/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/4q3mv2/investigation ) has announced ... Olmesartan Market, 2010-2019" report to their offering. ... by Sankyo Pharmaceuticals Co., Ltd and was patented in ... by FDA to enter the American market in May. ... the world after it succeeded in the US market. ...
(Date:9/3/2015)... Pharma major Lupin Limited ... (Lupin) has launched its Duloxetine 40 mg Delayed-Release ... generic Duloxetine formulation to become available in 40 ... this new strength to market, as it adds ... flexibility of treatment.      (Photo: ...
(Date:9/3/2015)... India , September 3, 2015 ... Metallic compounds, Organosulfurs, Organic acids, Phenolics, and Others) and ... & beverage, Paints & coatings, and Others) - Global ... and segments the Biocides Market with an analysis and ... as value. Browse   88 tables ...
Breaking Medicine Technology:China Olmesartan Investigation Market Report 2010-2019 2Lupin Launches First-ever Duloxetine 40mg Delayed-Release Capsules in the US 2Lupin Launches First-ever Duloxetine 40mg Delayed-Release Capsules in the US 3Lupin Launches First-ever Duloxetine 40mg Delayed-Release Capsules in the US 4Biocides Market Worth 10.6 Billion USD by 2020 2Biocides Market Worth 10.6 Billion USD by 2020 3Biocides Market Worth 10.6 Billion USD by 2020 4Biocides Market Worth 10.6 Billion USD by 2020 5
The workhorse electric system....
... BD Xstar Blade includes a specially designed, ... in prodedure and handling. The Xstar ... process for manufacturing surgical blades. This ... The arch style, single-bevel geometry allows ...
... The BD Safety Knife with BD ... retractable shield that protects the blade in ... technology is based on a grind-less process ... process yields outstanding sharpness and consistency. ...
... BD Xstar Blade includes a specially designed, ... in prodedure and handling. The Xstar ... process for manufacturing surgical blades. This ... The arch style, single-bevel geometry allows ...
Medicine Products: